Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, December 18, 2024
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
People on the Move
Cellares Appoints Ossama Eissa, Former Novartis, Lonza and Legend Biopharma Leader, as Chief Operating Officer
Life Sciences Times
-
November 12, 2024
0
Venture Capital
Bureau Veritas Continues to Build Capabilities in the Energy and Renewables Sector Through the Acquisition of Versatec Energy B.V.
Life Sciences Times
-
November 12, 2024
0
People on the Move
VarmX Announces Appointment of John Glasspool as CEO
Life Sciences Times
-
November 12, 2024
0
People on the Move
Healthcare Agency Veteran Allison Davis Joins CG Life as Chief Client Officer
Life Sciences Times
-
November 12, 2024
0
Biotech
Poster Presentation at International mRNA Health Conference Showcases Clinical Evidence that PharmaJet® Delivery Systems Enable mRNA Vaccine Delivery
Life Sciences Times
-
November 12, 2024
0
People on the Move
Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO
Life Sciences Times
-
November 11, 2024
0
People on the Move
Koneksa Appoints Eric Luthi as Chief Business Officer
Life Sciences Times
-
November 11, 2024
0
Medtech
Airgain Launches Its First Integrated Artificial Intelligence AT-Flight Asset Tracking Solution
Life Sciences Times
-
November 7, 2024
0
Medtech
Seventy-Six Percent of People With Diabetes Have Issues Transmitting Their Reading Using Bluetooth® Glucose Meters
Life Sciences Times
-
November 7, 2024
0
Medtech
Hyperfine Announces European Launch with CE Approval
Life Sciences Times
-
November 7, 2024
0
1
...
7
8
9
...
572
Page 8 of 572
Most Popular
VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO
December 16, 2024
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
December 16, 2024
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding
December 12, 2024
Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing
December 12, 2024
Load more
Recent Comments
Recent Comments